相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商:
Serpin Family B Member 4
- 库存:
4-6周
- 英文名:
Recombinant Human Serpin B4 Protein
- 规格:
50ug
别名:
Leupin; Peptidase inhibitor 11; PI 11; PI-11; PI11; Protease inhibitor (leucine serpin); SCCA 2; SCCA-2; SCCA1; SCCA2; SCCA2/SCCA1 fusion protein; Serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 4; Serpin B4; Serpin peptidase inhibitor, clade B (ovalbumin), member 4; SERPINB 4; SERPINB4; SPB4_HUMAN; Squamous cell carcinoma antigen 1; Squamous cell carcinoma antigen 2;
Recombinant Human Serpin B4 Protein, CF Summary
Asn2-Pro390
with an N-terminal Met and 6-His tag
Analysis
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
9437-PI
| Formulation | Lyophilized from a 0.2 μm filtered solution in Tris and NaCl. |
| Reconstitution | Reconstitute at 0.5 mg/mL in deionized water. |
| Shipping | The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Assay Procedure
- Maturation Buffer: 50 mM MES, pH 5.5
- Cathepsin Buffer: 50 mM MES, 50 mM NaCl, 5 mM DTT, pH 5.5
- Assay Buffer: 20 mM Tris, 2 M KCl, 0.02% (v/v) Triton® X-100, pH 9.0
- Recombinant Human Serpin B4 (rhSerpin B4) (Catalog # 9437-PI)
- Recombinant Human Chymase/CMA1 (rhChymase) (Catalog # 4099-SE)
- Recombinant Mouse Active Cathepsin C/DPPI (rmCathepsin C) (Catalog # 2336-CY)
- Heparin (Tocris, Catalog # 2812), 20 mg/mL stock in deionized water
- Substrate: Suc-Ala-Ala-Pro-Phe-AMC (Bachem, Catalog # I-1465), 10 mM stock in DMSO
- F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
- Fluorescent Plate Reader (Model: Gemini EM by Molecular Devices) or equivalent
- Dilute rhChymase-1 to 20 µg/mL in Maturation Buffer.
- Dilute rmCathepsin C to 20 µg/mL in Cathepsin Buffer.
- Dilute Heparin to 2.5 mg/mL in deionized water.
- Combine equal volumes of 20 µg/mL rhChymase and 20 µg/mL rmCathepsin.
- Add 2.5 mg/mL Heparin to the rhChymase mixture for a final concentration of 49 µg/mL.
- Incubate rhChymase mixture at room temperature for 1 hour.
- Dilute the rhChymase mixture to 4 µg/mL of rhChymase in Assay Buffer and incubate at room temperature for 5 minutes.
- Prepare a curve of rhSerpin B4 (MW: 45,677 Da) in Assay Buffer. Make the following serial dilutions: 2000, 500, 250, 125, 62.5, 31.25, 15.624, 7.812, 3.908 and 0.3908 nM.
- Combine equal volumes of each point of the rhSerpin B4 curve with 4 µg/mL rhChymase. Include an enzyme control containing equal volumes of Assay Buffer and 4 µg/mL CMA1.
- Incubate reaction mixtures at room temperature for 30 minutes.
- Dilute Substrate to 200 µM in Assay Buffer.
- Load 50 µL of the incubated mixtures into empty wells of a plate, and start the reaction by adding 50 µL of 200 µM Substrate. Include a Substrate Blank containing 50 µL of Assay Buffer and 50 µL of 200 µM Substrate.
- Read at excitation and emission wavelengths of 380 nm and 460 nm (top read), respectively, in kinetic mode for 5 minutes.
- Derive the 50% inhibition concentration (IC50) value for rhSerpin B4 by plotting RFU/min (or specific activity) versus concentration with 4-PL fitting.
- Calculate specific activity for rhChymase at each point using the following formula (if needed):
| Specific Activity (pmol/min/µg) = |
Adjusted Vmax* (RFU/min) x Conversion Factor** (pmol/RFU) |
| amount of enzyme (µg) |
*Adjusted for Substrate Blank.
**Derived using calibration standard 7-amino, 4-Methyl Coumarin (Sigma, Catalog # A9891).
rhSerpin B4: 500, 125, 62.5, 31.25, 15.625, 7.812, 3.906, 1.953, 0.977, and 0.0977 nM
rhChymase-1: 0.1 µg
Substrate: 100 µM
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验- Law, R. et al. (2006) Genome Biol. 7:216.
- Benarafa, C. and Remold-O'Donnell, E. (2005) Proc. Natl. Acad. Sci. 102:11367.
- Schick, C. et al. (1998) Proc. Natl. Acad. Sci. 95:13465.
- Song, K.J. et al. (2012) Korean J. Parasitol. 50:1.
- Ahmed, S.T. and Darnell, J.E. (2009) Biochem. Biophys. Res. Commun. 378:821.
- Catanzaro, J.M. et al. (2014) Cell Cycle 13:3155.
- Lysvand, H. et al. (2014) Biochim. Biophys. Acta. 1842:734.
- Iverson, O.J. et al. (2017) Clin. Immunol. 174:10.
Methods for Producing Recombinant Human Cellular Retinaldehyde-Binding Protein
The cellular retinaldehyde-binding protein (CRALBP) is expressed at high levels in vertebrate visual trssue, where it may serve to modulate the interaction of 11-cis -retinol with visual-cycle enzymes in the retinal pigment epithelium (RPE
Recombinant Protein Production in Yeasts
Recombinant protein production is a multibillion-dollar market. The development of a new product begins with the choice of a production host. While one single perfect host for every protein does not exist, several expression systems ranging
Recombinant Protein Expression in Nicotiana
Recombinant protein pharmaceuticals are now widely used in treatment of chronic diseases, and several recombinant protein subunit vaccines are approved for human and veterinary use. With growing demand for complex protein pharmaceuticals
技术资料暂无技术资料 索取技术资料







